Clinical trial
Angiogenesis in Early Breast Cancer for Prognosis Prediction
NCT00599105 is registered in ClinicalTrials.gov with University of California, Irvine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Angiogenesis in Early Breast Cancer for Prognosis Prediction
- Lead sponsor
- University of California, Irvine
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2000
- Completion date
- July 31, 2010
- Enrollment
- 700 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast lesions